Company intelligence / Profile preview
Purgo Biologics
Seongnam-si, Gyeonggi-do, South Koreaus.purgobio.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Purgo Biologics has a commercial portfolio of biomaterials for dental applications. Its products—including THE Graft™ bone mineral matrix, THE Cover™ collagen membrane, OpenTex® PTFE membrane—are used worldwide by clinicians for predictable outcomes in soft tissue and bone regeneration. The company’s solutions are supported by clinical studies and international regulatory approvals.
- Therapeutic areas
- Other
- Modalities
- Biologic (bone grafts and membranes derived from animal sources)Device (dental barrier membranes)Collagen-based biomaterial
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Distribution partnerships globally; specific partners not named
Beyond the preview
Go deeper on Purgo Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Purgo Biologics.